A detailed history of Atria Investments LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Atria Investments LLC holds 37,185 shares of DERM stock, worth $317,559. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,185
Previous 44,659 16.74%
Holding current value
$317,559
Previous $263,000 1.14%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025

SELL
$5.97 - $8.07 $44,619 - $60,315
-7,474 Reduced 16.74%
37,185 $266,000
Q1 2025

May 06, 2025

BUY
$3.66 - $6.54 $4,443 - $7,939
1,214 Added 2.79%
44,659 $263,000
Q4 2024

Feb 06, 2025

SELL
$3.97 - $6.53 $3,779 - $6,216
-952 Reduced 2.14%
43,445 $176,000
Q3 2024

Nov 01, 2024

SELL
$4.22 - $5.91 $46,166 - $64,655
-10,940 Reduced 19.77%
44,397 $250,000
Q2 2024

Aug 13, 2024

BUY
$3.31 - $5.94 $183,165 - $328,701
55,337 New
55,337 $312,000

Others Institutions Holding DERM

About Journey Medical Corp


  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $99M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.